Cholesterol homeostasis in two commonly used human prostate cancer cell-lines, LNCaP and PC-3

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Krycer, James Robert ^a   Kristiana, Ika ^a   Brown, Andrew John ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL STRAIN LNCAP; CELL STRAIN PC 3; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEEDBACK SYSTEM; GENE ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; PROMOTER REGION; PROSTATE CANCER; PROTEIN PROCESSING; PROTEIN TRANSPORT; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; MALE; METABOLISM; PROSTATE TUMOR; TUMOR CELL LINE; TUMOR GENE;

CELL LINE, TUMOR; CHOLESTEROL; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HOMEOSTASIS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, LDL; RESPONSE ELEMENTS; STEROL REGULATORY ELEMENT BINDING PROTEIN 2;

EID: 77949510089     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008496     Document Type: Article

References (51)

1. Swyer GIM (1942) The cholesterol content of normal and enlarged prostates. Cancer Res 2: 372-375.
2. Brown AJ (2007) Cholesterol, statins and cancer. Clin Exp Pharmacol Physiol 34: 135-141.
3. Hager MH, Solomon KR, Freeman MR (2006) The role of cholesterol in prostate cancer. Curr Opin Clin Nutr Metab Care 9: 379-385.
4. Solomon KR, Freeman MR (2008) Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 19: 113-121.
5. Locke JA, Wasan KM, Nelson CC, Guns ES, Leon CG (2008) Androgen-mediated cholesterol metabolism in LNCaP and PC-3 cell lines is regulated through two different isoforms of acyl-coenzyme A:Cholesterol Acyltransferase (ACAT). Prostate 68: 20-33.
6. Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96: 11041-11048.
7. Amemiya-Kudo M, Shimano H, Hasty AH, Yahagi N, Yoshikawa T, et al. (2002) Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res 43: 1220-1235.
8. Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, et al. (2003) Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci U S A 100: 12027-12032.
9. Chen Y, Hughes-Fulford M (2001) Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer 91: 41-45.
10. White C (1909) On the occurence of crystals in tumours. J Pathol Bacteriol 13: 3-10.
11. Sporer A, Brill DR, Schaffner CP (1982) Epoxycholesterols in secretions and tissues of normal, benign, and cancerous human prostate glands. Urology 20: 244-250.
12. Siperstein MD, Fagan VM (1964) Deletion of the Cholesterol-Negative Feedback System in Liver Tumors. Cancer Res 24: 1108-1115.
13. Tatidis L, Gruber A, Vitols S (1997) Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia. J Lipid Res 38: 2436-2445.
14. Cerda SR, Wilkinson J, Broitman SA (1995) Regulation of cholesterol synthesis in four colonic adenocarcinoma cell lines. Lipids 30: 1083-1092.
15. Hentosh P, Yuh SH, Elson CE, Peffley DM (2001) Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells. Mol Carcinog 32: 154-166.
16. Goldstein JL, DeBose-Boyd RA, Brown MS (2006) Protein sensors for membrane sterols. Cell 124: 35-46.
17. Warburg O (1930) The metabolism of tumours. London: Arnold Constable.
18. Galea AM, Brown AJ (2009) Special relationship between sterols and oxygen: were sterols an adaptation to aerobic life? Free Radic Biol Med 47: 880-889.
19. Grand-Perret T, Bouillot A, Perrot A, Commans S, Walker M, et al. (2001) SCAP ligands are potent new lipid-lowering drugs. Nat Med 7: 1332-1338.
20. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS (1995) Hairpin orientation of sterol regulatory element-binding protein-2 in cell membranes as determined by protease protection. J Biol Chem 270: 29422-29427.
21. Radhakrishnan A, Ikeda Y, Kwon HJ, Brown MS, Goldstein JL (2007) Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc Natl Acad Sci U S A 104: 6511-6518.
22. Goldstein JL, Basu SK, Brown MS (1983) Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98: 241-260.
23. Wong J, Quinn CM, Brown AJ (2007) Synthesis of the oxysterol, 24(S), 25-epoxycholesterol, parallels cholesterol production and may protect against cellular accumulation of newly-synthesized cholesterol. Lipids Health Dis 6: 10.
24. Kruth HS, Avigan J, Gamble W, Vaughan M (1979) Effect of cell density on binding and uptake of low density lipoprotein by human fibroblasts. J Cell Biol 83: 588-594.
25. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, et al. (2001) Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 15: 1817-1828.
26. Brown MS, Goldstein JL (1981) Lowering plasma cholesterol by raising LDL receptors. N Engl J Med 305: 515-517.
27. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, et al. (2005) Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc Natl Acad Sci U S A 102: 5374-5379.
28. McNutt MC, Kwon HJ, Chen C, Chen JR, Horton JD, et al. (2009) Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells. J Biol Chem 284: 10561-10570.
29. Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8: 512-521.
30. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, et al. (1983) LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818.
31. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23.
32. Heemers HV, Verhoeven G, Swinnen JV (2006) Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. Mol Endocrinol 20: 2265-2277.
33. Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, et al. (2004) Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 64: 2212-2221.
34. Liu J, Ahlborn TE, Briggs MR, Kraemer FB (2000) Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter. J Biol Chem 275: 5214-5221.
35. Dozmorov MG, Hurst RE, Culkin DJ, Kropp BP, Frank MB, et al. (2009) Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells. Prostate 69: 1077-1090.
36. Sharrard RM, Maitland NJ (2007) Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines. Cell Signal 19: 129-138.
37. Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, et al. (2007) Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7: 64.
38. Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, et al. (2004) Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 164: 217-227.
39. Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, et al. (2007) Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39: 41-51.
40. Morris DS, Tomlins SA, Rhodes DR, Mehra R, Shah RB, et al. (2007) Integrating biomedical knowledge to model pathways of prostate cancer progression. Cell Cycle 6: 1177-1187.
41. Lin J, Adam RM, Santiestevan E, Freeman MR (1999) The phosphatidylinositol 39-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res 59: 2891-2897.
42. Chung LWK (1996) LNCaP human prostate cancer progression model. Urologic Oncology: Seminars and Original Investigations 2: 99-128.
43. Masquelier M, Lundberg B, Peterson C, Vitols S (2006) Cytotoxic effect of a lipophilic alkylating agent after incorporation into low density lipoprotein or emulsions: studies in human leukemic cells. Leuk Res 30: 136-144.
44. Ades A, Carvalho JP, Graziani SR, Amancio RF, Souen JS, et al. (2001) Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 82: 84-87.
45. Piperno G, LeDizet M, Chang XJ (1987) Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104: 289-302.
46. Du X, Kristiana I, Wong J, Brown AJ (2006) Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17: 2735-2745.
47. Wong J, Quinn CM, Gelissen IC, Brown AJ (2008) Endogenous 24(S),25- epoxycholesterol fine-tunes acute control of cellular cholesterol homeostasis. J Biol Chem 283: 700-707.
48. Wong J, Quinn CM, Brown AJ (2004) Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux. Arterioscler Thromb Vasc Biol 24: 2365-2371.
49. Liu J, Streiff R, Zhang YL, Vestal RE, Spence MJ, et al. (1997) Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M. J Lipid Res 38: 2035-2048.
50. Stephan ZF, Yurachek EC (1993) Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res 34: 325-330.
51. Teupser D, Thiery J, Walli AK, Seidel D (1996) Determination of LDL- and scavenger-receptor activity in adherent and non-adherent cultured cells with a new single-step fluorometric assay. Biochim Biophys Acta 1303: 193-198.